|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Winslow MM, Dayton TL, Verhaak RG,
Kim-Kiselak C, Snyder EL, Feldser DM, Hubbard DD, DuPage MJ,
Whittaker CA, Hoersch S, et al: Suppression of lung adenocarcinoma
progression by Nkx2-1. Nature. 473:101–104. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mishra M, Morgan V, Hamati AK and
Al-Abbadi M: Carcinoma of unknown primary: Check the liver… thanks
to TTF-1. Tenn Med. 105:35–36. 2012.PubMed/NCBI
|
|
4
|
Ye J, Findeis-Hosey JJ, Yang Q, McMahon
LA, Yao JL, Li F and Xu H: Combination of napsin A and TTF-1
immunohistochemistry helps in differentiating primary lung
adenocarcinoma from metastatic carcinoma in the lung. Appl
Immunohistochem Mol Morphol. 19:313–317. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nakamura N, Miyagi E, Murata S, Kawaoi A
and Katoh R: Expression of thyroid transcription factor-1 in normal
and neoplastic lung tissues. Mod Pathol. 15:1058–1067. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tang X, Kadara H, Behrens C, Liu DD, Xiao
Y, Rice D, Gazdar AF, Fujimoto J, Moran C, Varella-Garcia M, et al:
Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC:
Implications in lung cancer pathogenesis and prognosis. Clin Cancer
Res. 17:2434–2443. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tanaka H, Yanagisawa K, Shinjo K, Taguchi
A, Maeno K, Tomida S, Shimada Y, Osada H, Kosaka T, Matsubara H, et
al: Lineage-specific dependency of lung adenocarcinomas on the lung
development regulator TTF-1. Cancer Res. 67:6007–6011. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bai XY and Shen H: Quantitative analysis
of thyroid transcription factor-1 mRNA expressions in primary lung
cancer and its metastatic foci. Nan Fang Yi Ke Da Xue Xue Bao.
28:20–25. 2008.(In Chinese). PubMed/NCBI
|
|
9
|
Feng RE: IASLC/ATS/ERS international
multidisciplinary new classification of lung adenocarcinoma and its
clinical significance. Zhonghua Jie He He Hu Xi Za Zhi. 35:95–96.
2012.(In Chinese). PubMed/NCBI
|
|
10
|
Li X, Wan L, Shen H, Geng J, Nie J, Wang
G, Jia N, Dai M and Bai X: Thyroid transcription factor-1
amplification and expressions in lung adenocarcinoma tissues and
pleural effusions predict patient survival and prognosis. J Thorac
Oncol. 7:76–84. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li X, Wan L, Geng J, Wu CL and Bai X:
Aldehyde dehydrogenase 1A1 possesses stem-like properties and
predicts lung cancer patient outcome. J Thorac Oncol. 7:1235–1245.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang H, Bai X, Zhang C and Zhang X:
Evaluation of Her2 gene amplification in breast cancer using nuclei
microarray in situ hybridization. Int J Mol Sci. 13:5519–5527.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma H, Zhang X, Zhang X, Yang D, Meng L,
Zhang Y and Zhou S: The effect of esculentoside A on lupus
nephritis-prone BXSB mice. Arch Med Sci. 9:354–360. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Landis JR and Koch GG: A one-way
components of variance model for categorical data. Biometric.
33:671–679. 1977. View
Article : Google Scholar
|
|
15
|
Kononen J, Bubendorf L, Kallioniemi A,
Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G
and Kallioniemi OP: Tissue microarrays for high-throughput
molecular profiling of tumor specimens. Nat Med. 4:844–847. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rimm DL, Camp RL, Charette LA, Olsen DA
and Provost E: Amplification of tissue by construction of tissue
microarrays. Exp Mol Pathol. 70:255–264. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
von Wasielewski R, Mengel M, Wiese B,
Rüdiger T, Müller-Hermelink HK and Kreipe H: Tissue array
technology for testing interlaboratory and interobserver
reproducibility of immunohistochemical estrogen receptor analysis
in a large multicenter trial. Am J Clin Pathol. 118:675–682. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Braunschweig T, Chung JY and Hewitt SM:
Tissue microarrays: Bridging the gap between research and the
clinic. Expert Rev Proteomics. 2:325–336. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fennell DA, Myrand SP, Nguyen TS, Ferry D,
Kerr KM, Maxwell P, Moore SD, Visseren-Grul C, Das M and Nicolson
MC: Association between gene expression profiles and clinical
outcome of pemetrexed-based treatment in patients with advanced
non-squamous non-small cell lung cancer: exploratory results from a
phase II study. PLoS One. 9:e1074552014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kapila K, Al-Ayadhy B, Francis IM, George
SS and Al-Jassar A: Subclassification of pulmonary non-small cell
lung carcinoma in fine needle aspirates using a limited
immunohistochemistry panel. J Cytol. 30:223–225. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kalhor N, Zander DS and Liu J: TTF-1 and
p63 for distinguishing pulmonary small-cell carcinoma from poorly
differentiated squamous cell carcinoma in previously pap-stained
cytologic material. Mod Pathol. 19:1117–1123. 2006.PubMed/NCBI
|
